Reuters -- French drugmaker Sanofi-Aventis (SASY.PA) has settled a patent law suit over cancer drug Eloxatin, putting a block on several other drugmakers selling their generic versions from late June until August 2012.
Reuters -- French drugmaker Sanofi-Aventis (SASY.PA) has settled a patent law suit over cancer drug Eloxatin, putting a block on several other drugmakers selling their generic versions from late June until August 2012.
